218 related articles for article (PubMed ID: 3054355)
61. [Oral therapy of diabetes. Suggestions and requirements for use].
Hasselblatt A
ZFA (Stuttgart); 1982 Sep; 58(26):1384-9. PubMed ID: 7180121
[No Abstract] [Full Text] [Related]
62. [Simplified combination treatment of diabetes mellitus with sulfonylurea compounds and biguanides].
Bock E
Z Allgemeinmed; 1975 Jan; 51(1):37. PubMed ID: 1216880
[No Abstract] [Full Text] [Related]
63. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
Goo AK; Carson DS; Bjelajac A
J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
[TBL] [Abstract][Full Text] [Related]
64. [Combined administration of oral agents in insulin therapy].
Oneta A
Nihon Rinsho; 1973 Jul; 31(7):2293-7. PubMed ID: 4795330
[No Abstract] [Full Text] [Related]
65. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
Bell DS
Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
[TBL] [Abstract][Full Text] [Related]
66. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).
Lentini S; Bossini A; Pirola LC
Arzneimittelforschung; 1972 Jul; 22(7):1169-73. PubMed ID: 4678124
[No Abstract] [Full Text] [Related]
67. [Combined administration of insulin and oral agents].
Tasaka H
Nihon Rinsho; 1973 Jul; 31(7):2286-93. PubMed ID: 4795329
[No Abstract] [Full Text] [Related]
68. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
Mehnert H
Dtsch Med Wochenschr; 1989 Jul; 114(27):1086-8. PubMed ID: 2500320
[No Abstract] [Full Text] [Related]
69. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
Harrigan RA; Nathan MS; Beattie P
Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
[TBL] [Abstract][Full Text] [Related]
70. Clinical experience with glipizide in the treatment of mostly complicated diabetes.
Masbernard A; Giudicelli C; Massey J
Diabetologia; 1973 Sep; ():356-63. PubMed ID: 4772981
[No Abstract] [Full Text] [Related]
71. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
Jaillard J; Warembourg H
Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429
[No Abstract] [Full Text] [Related]
72. [Diabetes therapy using oral antidiabetics].
Hasslacher C; Wahl P
Z Allgemeinmed; 1972 Apr; 48(12):583-7. PubMed ID: 5034166
[No Abstract] [Full Text] [Related]
73. [Oral hypoglycemic agents].
Pupo Ade A
AMB Rev Assoc Med Bras; 1986; 32(11-12):202-4. PubMed ID: 3299518
[No Abstract] [Full Text] [Related]
74. Oral hypoglycemic agents.
Boyden T; Bressler R
Adv Intern Med; 1979; 24():53-70. PubMed ID: 371368
[No Abstract] [Full Text] [Related]
75. Clinical experiences in oral antidiabetic therapy with sulphonylureas and biguanides.
Schöffling K
Aust N Z J Med; 1971 Aug; 1():Suppl 2:47-56. PubMed ID: 5005131
[No Abstract] [Full Text] [Related]
76. Blood lactate and pyruvate levels in diabetic patients treated with biguanides with and without sulphonylureas.
Waters AK; Morgan DB; Wales JK
Diabetologia; 1978 Feb; 14(2):95-8. PubMed ID: 631461
[TBL] [Abstract][Full Text] [Related]
77. [Hypoglycemic sulfamides and biguanides].
Curchod B
Z Krankenpfl; 1972 May; 65(5):190-3. PubMed ID: 4482790
[No Abstract] [Full Text] [Related]
78. The pharmacology of sulfonylureas.
Skillman TG; Feldman JM
Am J Med; 1981 Feb; 70(2):361-72. PubMed ID: 6781341
[TBL] [Abstract][Full Text] [Related]
79. [Recent development in the diabetes-therapy].
Landgraf R; Dieterle C
Internist (Berl); 1977 Oct; 18(10):509-19. PubMed ID: 412809
[No Abstract] [Full Text] [Related]
80. Use of sulfonylurea agents in older diabetic patients.
Peters AL; Davidson MB
Clin Geriatr Med; 1990 Nov; 6(4):903-21. PubMed ID: 2224754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
